“…[54][55][56][57] Permanently implanted neurostimulation (eg, spinal cord stimulation [SCS]) systems can reduce pain, opioid use, and disability, 58-67 but traditionally multifactorial etiology pain, as is common among those with chronic LBP, has been difficult to successfully treat conventionally. [68][69][70] Due in part to the invasiveness, risks of the surgery and implantation of leads near the spinal cord, high complication rate, [71][72][73][74][75][76] and associated expense, SCS is typically relegated to a treatment of last resort (ie, only employed after other therapies have failed) and only used in about 5% of candidates. 77 An effective and less invasive system is needed that does not have the costs, risks, complications, and delayed care associated with previous therapies, 78,79 especially if such a system may permit short-term use to interrupt the cycle of chronic pain and provides longterm pain relief that prevents the recurrence of pain or the need for surgery or a permanent implant.…”